STOCK TITAN

Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
partnership

Perrigo (NYSE: PRGO) announced a new partnership between Good Start® and Dr. Brown's® to launch an infant formula portfolio. The collaboration aims to provide trusted infant formula solutions like Soothe Pro™ and Gentle Pro™ with new packaging. Good Start® has been a reliable brand for over 50 years, while Dr. Brown's® is known for its top pediatrician-recommended baby bottles. The new formulas are designed to address tolerance concerns and offer complete nutrition. Soothe Pro™ contains probiotic L. reuteri, and Gentle Pro™ includes probiotic B. lactis. Additionally, Soy-ease Pro™ is formulated with plant-based proteins for babies with lactose sensitivity. These products are available at major retailers like Walmart and Amazon. Perrigo's strategy focuses on consumer-led innovation to enhance the feeding experience for families.

Perrigo (NYSE: PRGO) ha annunciato una nuova partnership tra Good Start® e Dr. Brown's® per lanciare un portafoglio di formule per neonati. La collaborazione mira a fornire soluzioni affidabili per la formula infantile come Soothe Pro™ e Gentle Pro™ con un nuovo packaging. Good Start® è stata un marchio affidabile per oltre 50 anni, mentre Dr. Brown's® è conosciuto per i suoi biberon raccomandati dai pediatri. Le nuove formule sono progettate per affrontare le preoccupazioni di tolleranza e offrire una nutrizione completa. Soothe Pro™ contiene il probiotico L. reuteri, e Gentle Pro™ include il probiotico B. lactis. Inoltre, Soy-ease Pro™ è formulato con proteine vegetali per i neonati con sensibilità al lattosio. Questi prodotti sono disponibili presso i principali rivenditori come Walmart e Amazon. La strategia di Perrigo si concentra sull'innovazione guidata dai consumatori per migliorare l'esperienza di alimentazione delle famiglie.

Perrigo (NYSE: PRGO) anunció una nueva asociación entre Good Start® y Dr. Brown's® para lanzar un portafolio de fórmulas infantiles. La colaboración tiene como objetivo proporcionar soluciones confiables de fórmula infantil como Soothe Pro™ y Gentle Pro™ con un nuevo empaque. Good Start® ha sido una marca confiable por más de 50 años, mientras que Dr. Brown's® es conocido por sus biberones recomendados por pediatras. Las nuevas fórmulas están diseñadas para abordar preocupaciones de tolerancia y ofrecer nutrición completa. Soothe Pro™ contiene el probiótico L. reuteri, y Gentle Pro™ incluye el probiótico B. lactis. Además, Soy-ease Pro™ está formulado con proteínas vegetales para bebés con sensibilidad a la lactosa. Estos productos están disponibles en grandes minoristas como Walmart y Amazon. La estrategia de Perrigo se centra en la innovación impulsada por los consumidores para mejorar la experiencia de alimentación de las familias.

Perrigo (NYSE: PRGO)는 Good Start®Dr. Brown's® 간의 새로운 파트너십을 발표하며 아기 분유 제품군을 출시합니다. 이 협력은 새로운 포장으로 Soothe Pro™Gentle Pro™와 같은 믿을 수 있는 아기 분유 솔루션을 제공하는 것을 목표로 합니다. Good Start®은 50년 넘게 신뢰받아 온 브랜드이며, Dr. Brown's®은 최고의 소아과 의사 추천 아기병으로 유명합니다. 새로운 포뮬러는 내성 문제를 해결하고 완벽한 영양을 제공합니다. Soothe Pro™는 프로바이오틱 L. reuteri를 포함하고, Gentle Pro™는 프로바이오틱 B. lactis를 포함합니다. 또한, Soy-ease Pro™는 유당에 민감한 아기를 위한 식물성 단백질로 제조되었습니다. 이 제품들은 Walmart와 Amazon과 같은 주요 소매점에서 구입할 수 있습니다. Perrigo의 전략은 가족의 수유 경험을 향상시키기 위한 소비자 주도 혁신에 중점을 두고 있습니다.

Perrigo (NYSE: PRGO) a annoncé un nouveau partenariat entre Good Start® et Dr. Brown's® pour lancer un portefeuille de formules pour nourrissons. Cette collaboration vise à fournir des solutions fiables en matière de formules infantiles comme Soothe Pro™ et Gentle Pro™ avec un nouvel emballage. Good Start® est une marque fiable depuis plus de 50 ans, tandis que Dr. Brown's® est reconnu pour ses biberons recommandés par les pédiatres. Les nouvelles formules sont conçues pour répondre aux préoccupations de tolérance et offrir une nutrition complète. Soothe Pro™ contient le probiotique L. reuteri, et Gentle Pro™ inclut le probiotique B. lactis. De plus, Soy-ease Pro™ est formulé avec des protéines végétales pour les bébés sensibles au lactose. Ces produits sont disponibles dans les grands détaillants tels que Walmart et Amazon. La stratégie de Perrigo se concentre sur l'innovation dirigée par le consommateur pour améliorer l'expérience d'alimentation des familles.

Perrigo (NYSE: PRGO) kündigte eine neue Partnerschaft zwischen Good Start® und Dr. Brown's® an, um ein Portfolio von Säuglingsnahrungen einzuführen. Die Zusammenarbeit zielt darauf ab, vertrauenswürdige Säuglingsnahrungslösungen wie Soothe Pro™ und Gentle Pro™ mit neuer Verpackung anzubieten. Good Start® ist seit über 50 Jahren eine zuverlässige Marke, während Dr. Brown's® für seine von Kinderärzten empfohlenen Babyflaschen bekannt ist. Die neuen Formeln sind darauf ausgelegt, Toleranzprobleme anzugehen und eine vollständige Ernährung zu bieten. Soothe Pro™ enthält das Probiotikum L. reuteri, und Gentle Pro™ enthält das Probiotikum B. lactis. Darüber hinaus ist Soy-ease Pro™ mit pflanzlichen Proteinen für Babys mit Laktoseempfindlichkeit formuliert. Diese Produkte sind bei großen Einzelhändlern wie Walmart und Amazon erhältlich. Perrigos Strategie konzentriert sich auf verbraucherorientierte Innovationen zur Verbesserung des Fütterungserlebnisses für Familien.

Positive
  • New partnership between Good Start® and Dr. Brown's® to launch an infant formula portfolio.
  • Trusted brands with over 50 years of experience in infant nutrition and pediatrician-recommended products.
  • Formulas designed to address tolerance concerns, providing complete nutrition.
  • Availability of products at major retailers like Walmart and Amazon.
Negative
  • None.

Insights

This partnership between Good Start® and Dr. Brown's® is a strategic move for Perrigo in the infant formula market. By combining Good Start's 50-year legacy in infant nutrition with Dr. Brown's® reputation as the No. 1 pediatrician-recommended baby bottle brand, Perrigo is positioning itself to capture a larger share of the tolerance-focused formula segment.

The focus on formulas addressing fussiness, gas and spit-up aligns with market trends, as tolerance issues are the top reason for formula switching. This targeted approach could lead to increased customer loyalty and potentially higher margins.

The immediate availability in major retailers like Walmart, Amazon and Kroger suggests a strong distribution strategy, which is important for market penetration. However, the impact on Perrigo's financials may take time to materialize, as brand partnerships often require significant marketing investments to gain traction.

While this move strengthens Perrigo's position in the infant formula market, investors should monitor how it affects the company's overall Consumer Self-Care segment performance in the coming quarters.

DUBLIN, Sept. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown's®2 infant formula solutions. Good Start®, a trusted infant formula brand for over 50 years, and Dr. Brown's®, makers of the No. 1 pediatrician-recommended baby bottle in the U.S.3, share a long-time mission of creating confident feeding experiences for families.

The new Good Start® | Dr. Brown's™ portfolio will offer the same trusted infant formula products as the existing Soothe Pro™ and Gentle Pro™, now with refreshed packaging to celebrate the launch of the new partnership. Good Start® | Dr. Brown's™ infant formulas offer complete nutrition specially formulated for tolerance concerns.

Perrigo Executive Vice President and President of Consumer Self-Care Americas, Triona Schmelter commented, "We are delighted to announce this branded infant formula partnership with the exceptional team at Dr. Brown's®. Formula tolerance issues are the top reason for parents and caregivers to switch formulas 4, and bringing these two trusted infant brands together helps families confidently navigate their baby's formula-feeding journey. This new and innovative Good Start® and Dr. Brown's® partnership epitomizes Perrigo's blended-branded strategy dedicated to consumer led innovation."

"For 25 years, Dr. Brown's® has made innovative feeding products that are trusted by parents and caretakers throughout the world to promote good health and optimal nutrition for babies and toddlers," said Scott Rhodes, Chief Operating Officer at Dr. Brown's®. "Now, by partnering with Good Start ®, we're thrilled to add another offering families can choose to include as part of their feeding journey." 

The Good Start® | Dr. Brown's™ infant formula line includes:

  • Soothe Pro™ infant formula: Formulated with probiotic L. reuteri and helps reduce fussiness with the first bottle.5 It provides complete nutrition for babies experiencing gas, fussiness and spit-ups.
  • Gentle Pro™ infant formula: Provides complete nutrition and promotes easy digestion and softer stools.6 Gentle Pro™ includes the probiotic B. lactis, a gut-friendly probiotic like the ones found in breast milk.
  • Soy-ease Pro™ infant formula: Milk and lactose-free, made with 100% plant-based proteins. Provides complete nutrition for babies with fussiness and gas due to milk or lactose sensitivity.

Good Start® and Dr. Brown's® are dedicated to supporting parents, caregivers and the medical community by supporting optimal nutrition solutions.

For more information about Good Start® | Dr. Brown's™ formulas, please visit www.goodstartbaby.com. The formulas are now available in major retailers including Walmart, Amazon, Kroger and others.

1GOOD START is a registered trademark used under license from Société des Produits Nestlé S.A.
2Dr. Brown's is a trademark used under license from the Dr. Brown's Company
3 IQVIA Health ProVoice Survey 2023
4 Infant formula category brand tracking 2023, August 2023, Ravel.
5Study results among parents of fussy infants. Czerkies L, et al. Int J Pediatr. 2018:4676758
6Compared to intact protein formulas. Czerkies L, et al. Int J Pediatr. 2018:4676758

About Good Start® | Dr. Brown's™ Infant Formula Solutions

Good Start® | Dr. Brown's™ infant formula provides parents with high-quality, trusted infant formulas to create confident feeding experiences. Understanding how stressful it can be when a baby suffers from fussiness, spit-up, gas and more, Good Start® | Dr. Brown's™ infant formula solutions aim to help parents get back to the good parts of parenting with tolerance-focused solutions. Good Start® | Dr. Brown's™ Gentle Pro™ and Soothe Pro™ infant formulas are unique with gut-friendly probiotics, 100% whey proteins, free from casein curdling and made using an advanced two-step hydrolysis process, which breaks down intact proteins to make them easier to digest. For more information, visit www.goodstartbaby.com.

About Dr. Brown's Company

Dr. Brown's® is dedicated to providing well-designed, healthful feeding products for babies. The Dr. Brown's® lines of baby bottles, breastfeeding products, pacifiers, teethers, training cups, solid feeding and baby care products are regarded for their technology and function. Dr. Brown's® bottles have won 17 consecutive Parents/American Baby awards. The Dr. Brown's® Anti-Colic Options+™ bottles earned "Best Glass Bottle" in the 2024 Parents Magazine Best for Baby Awards, and Dr. Brown's® as a brand won "Best Bottle Brand" in the 2024 What to Expect Feeding Awards. Dr. Brown's® products are available at baby specialty and online retailers worldwide. For more information, visit drbrownsbaby.com.  

About Perrigo 

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com.

Perrigo Forward-Looking Statements

Certain statements in this press release are "forward-looking statements." These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. The Company bases these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control, including those caused or exacerbated by armed conflict, trade and other economic sanctions and/or disease; general economic, credit, and market conditions; customer acceptance of new products; competition from other industry participants; pricing pressures from customers and consumers; ongoing or future government investigations and regulatory initiatives; uncertainty regarding the Company's ability to obtain and maintain its regulatory approvals; potential costs and reputational impact of product recalls or sales halts; and the Company's ability to execute and achieve the desired benefits of the brand partnership described herein. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2023, as well as the Company's subsequent filings with the United States Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements.

Dr. Brown's Media Contact

Kara Hamstra, Senior Director, The Agency at Sikich, E-mail: kara.hamstra@sikich.com 

Perrigo Media Contact

Madeline Nance, DJE Holdings, E-mail: madeline.nance@salutemcomms.com

Perrigo Investor Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373,
E-mail: bradley.joseph@perrigo.com
Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238,
E-mail: nicholas.gallagher@perrigo.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-announces-good-start-and-dr-browns-brand-partnership-and-launch-of-infant-formula-portfolio-302259885.html

SOURCE Perrigo Company plc

FAQ

What is the new partnership announced by Perrigo involving PRGO?

Perrigo announced a partnership between Good Start® and Dr. Brown's® to launch a new infant formula portfolio.

What products are included in the Good Start® | Dr. Brown's™ infant formula line?

The product line includes Soothe Pro™, Gentle Pro™, and Soy-ease Pro™ infant formulas.

Where can I buy the Good Start® | Dr. Brown's™ infant formulas?

The formulas are available at major retailers including Walmart, Amazon, and Kroger.

What are the key features of Soothe Pro™ infant formula?

Soothe Pro™ contains probiotic L. reuteri and is designed to reduce fussiness, gas, and spit-ups.

What makes Gentle Pro™ infant formula unique?

Gentle Pro™ includes probiotic B. lactis and promotes easy digestion and softer stools.

PERRIGO COMPANY PLC

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Stock Data

3.40B
136.42M
0.34%
97.77%
3.72%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 2